This study is in progress, not accepting new patients
Study of ABT-199 (GDC-0199) in Combination With Azacitidine or Decitabine (Chemo Combo) in Subjects With Acute Myelogenous Leukemia (AML)
Summary
- Eligibility
- for people ages 60 years and up (full criteria)
- Location
- at UC Davis
- Dates
- study startedestimated completion
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- AbbVie
- ID
- NCT02203773
- Phase
- Phase 1/2
- Study Type
- Interventional
- Last Updated